Muscle wasting and atrophy, not elsewhere classified

DOID EFO MESH PheWeb

M13_MUSCLEATROPH

muscular disease: Acquired, familial, and congenital disorders of skeletal muscle and smooth muscle.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Hospital Discharge: ICD-10 M62.5

Hospital discharge: ICD-9 7282A

Hospital discharge: ICD-8 7331

Cause of death: ICD-10 M62.5

Cause of death: ICD-9 7282A

Cause of death: ICD-8 7331

155

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

129

Check minimum number of events None

129

Include endpoints None

129

M13_MUSCLEATROPH

Extra metadata

Level in the ICD hierarchy 4

First used in FinnGen datafreeze DF2

Parent code in ICD-10 M62

Name in latin Atrophia et degeneratio musculi non alibi classificatae

Similar endpoints

↥

List of similar endpoints to Muscle wasting and atrophy, not elsewhere classified based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	126	63	63
Unadjusted prevalence (%)	0.04	0.04	0.05
Mean age at first event (years)	54.02	51.44	56.61

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	-	-	-	-
15 years	-	-	-	-
5 years	-	-	-	-
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: M13_MUSCLEATROPH – Muscle wasting and atrophy, not elsewhere classified
GWS hits: 0

Survival analyses between endpoints

↥

Plot

before Muscle wasting and atrophy, not elsewhere classified
after Muscle wasting and atrophy, not elsewhere classified

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Muscle wasting and atrophy, not elsewhere classified

↥